Zhipei Sang

Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer’s disease

Zhipei Sang, Keren Wang, Jian Shi et al. · European Journal of Medicinal Chemistry · 2019 · 95 citations · Full text

Multi-target-directed Liagnds, Neurodegenerative Diseases, Drug Target +11

Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer's disease

Zhipei Sang, Keren Wang, Pengfei Zhang et al. · European Journal of Medicinal Chemistry · 2019 · 82 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Derivative (Chemistry) +11

Design, Synthesis, and Evaluation of Novel Ferulic Acid Derivatives as Multi-Target-Directed Ligands for the Treatment of Alzheimer’s Disease

Zhipei Sang, Keren Wang, Xue Han et al. · ACS Chemical Neuroscience · 2018 · 81 citations

The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer’s disease

Zhipei Sang, Keren Wang, Jian Shi et al. · European Journal of Medicinal Chemistry · 2020 · 70 citations · Full text

Advanced Structural Framework, Drug Target, Alzheimer's Disease +9

Design, synthesis and biological evaluation of 4′-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease

Ganyuan Xiao, Yan Li, Xiaoming Qiang et al. · Bioorganic & Medicinal Chemistry · 2016 · 69 citations · Full text

4′-Aminochalcone-rivastigmine Hybrids, Medicine, Drug Discovery +8